Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR2E3 | Q9Y5X4 | 10/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26597189 | 1.00 | NR2E3 (0.62) | NR2E3MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL26753631 | 0.92 | MAPT (0.57) | NR2E3MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL26597175 | 0.85 | NR2E3 (0.62) | NR2E3MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL31748600 | 0.85 | NR2E3 (0.62) | NR2E3MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL31748726 | 0.83 | MMP2 (0.70) | NR2E3MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL26597181 | 0.83 | MMP2 (0.70) | NR2E3MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL23657606 | 0.82 | KMT2A (0.55) | NR2E3MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL3202423 | 0.77 | ALDH1A1 (0.63) | NR2E3MAPTTP53KDM4EALDH1A1 | |
| SCHEMBL31748608 | 0.75 | NR2E3 (0.63) | NR2E3MAPTKDM4EALDH1A1KMT2A | |
| SCHEMBL26597196 | 0.75 | NR2E3 (0.63) | NR2E3MAPTKDM4EALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388551-A1 | COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS | UNIV PARIS CITE (FR) | 2025-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388551-A1 | COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS | CXCL10, CCR10, IL2 | NR2E3 2814/4885MAPT 4593/4885TP53 3721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.